Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**Heterogeneous nuclear ribonucleoprotein K pseudogene 5 (HNRNPKP5)** is a pseudogene; it is a non-protein-coding genomic sequence derived from the parental *HNRNPK* gene, part of the heterogeneous nuclear ribonucleoprotein (hnRNP) family. Pseudogenes like HNRNPKP5 typically contain mutations or deletions that prevent them from encoding functional proteins and, as noted for the hnRNP K pseudogene subfamily, there is no evidence for functional protein production from HNRNPKP5[1][3][7]. Although some pseudogenes are transcribed and might have regulatory RNA functions, HNRNPKP5 has not been characterized as a therapeutic target or as a disease-associated locus. Its status as a pseudogene indicates it does not serve as an enzyme, receptor, transporter, or other canonical molecular target class, nor is it currently implicated in any biological functions, pathologies, or pharmacologic interactions[1][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein K pseudogene 5 (HNRNPKP5).